Cystatin SN neutralizes the inhibitory effect of cystatin C on cathepsin B activity

Cystatin SN (CST1) is one of the several salivary cystatins that form tight equimolar complexes with cysteine proteases, such as the cathepsins. High expression of CST1 is correlated with advanced pTNM stage in gastric cancer. However, the functional role of CST1 in tumorigenesis has not been elucidated. In this study, we showed that CST1 was highly expressed in colon tumor tissues, compared with nontumor regions. Increased cell proliferation and invasiveness were observed in HCT116 cell lines stably transfected with CST1 cDNA (HCT116-CST1) but not in CST3-transfected cells. We also demonstrated that CST1-overexpressing cell lines exhibited increased tumor growth as well as metastasis in a xenograft nude mouse model. Interestingly, CST1 interacted with cystatin C (CST3), a potent cathepsin B (CTSB) inhibitor, with a higher affinity than the interaction between CST3 and CTSB in the extracellular space of HCT116 cells. CTSB-mediated cellular invasiveness and proteolytic activities were strongly inhibited by CST3, but in the presence of CST1 CTSB activities recovered significantly. Furthermore, domain mapping of CST1 showed that the disulfide-bonded conformation, or conserved folding, of CST1 is important for its secretion and for the neutralization of CST3 activity. These results suggest that CST1 upregulation might be involved in colorectal tumorigenesis and acts by neutralizing the inhibition of CTSB proteolytic activity by CST3.

[1]  A. Barrett.  The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.

[2]  D. Turk,et al.  Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.

[3]  G. Gudmundsson,et al.  The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids , 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[4]  T. Lee,et al.  Structure/Function Analysis of Human Cystatin SN and Comparison of the Cysteine Proteinase Inhibitory Profiles of Human Cystatins C and SN , 1999, Journal of dental research.

[5]  N. Darmani,et al.  Inhibition of B16 melanoma metastasis by overexpression of the cysteine proteinase inhibitor cystatin C. , 1999, Melanoma research.

[6]  M. Levine,et al.  Biological activities and secondary structures of variant forms of human salivary cystatin SN produced in Escherichia coli. , 1994, Gene.

[7]  A. Albini,et al.  Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin C , 1999, International journal of cancer.

[8]  I J Christensen,et al.  Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  J. Ott,et al.  Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. , 2006, The Journal of investigative dermatology.

[10]  J. Featherstone,et al.  Functional aspects of the human salivary cystatins in the oral environment. , 2008, Oral diseases.

[11]  H. Wiśniewski,et al.  Human cystatin C forms an inactive dimer during intracellular trafficking in transfected CHO cells , 1997, Journal of cellular physiology.

[12]  H. Nielsen,et al.  Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  M. Siciliano,et al.  Direct mapping of seven genes encoding human type 2 cystatins to a single site located at 20p11.2. , 1994, Genomics.

[14]  A. Anisowicz,et al.  Identification, Cloning, and Characterization of Cystatin M, a Novel Cysteine Proteinase Inhibitor, Down-regulated in Breast Cancer* , 1997, The Journal of Biological Chemistry.

[15]  J. Kos,et al.  Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  M. Abrahamson,et al.  Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. , 1992, The Biochemical journal.

[17]  Bonnie F. Sloane,et al.  Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.

[18]  M. Levine,et al.  Cystatins--inhibitors of cysteine proteinases. , 1992, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[19]  Jean Wu,et al.  Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis. , 2003, Oral oncology.

[20]  J. Potempa,et al.  Bacterial proteinases as targets for the development of second-generation antibiotics. , 2000, Biochimica et biophysica acta.

[21]  J. Kos,et al.  Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma. , 2007, Cancer letters.

[22]  Zbigniew Grzonka,et al.  Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping , 2001, Nature Structural Biology.

[23]  Lippincott-Schwartz,et al.  Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .

[24]  Christopher M Overall,et al.  Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. , 2006, Nature reviews. Cancer.

[25]  M. Filipič,et al.  Effect of Cysteine Proteinase Inhibitors on Murine B16 Melanoma Cell Invasion in vitro , 2002, Biological chemistry.

[26]  M. Abrahamson,et al.  Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. , 1990, Scandinavian journal of clinical and laboratory investigation.

[27]  W. Bode,et al.  The 2.0 A X‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. , 1988, The EMBO journal.

[28]  E. Veerman,et al.  Cystatins in health and disease. , 1996, Biological chemistry Hoppe-Seyler.

[29]  T. Barka,et al.  Cysteine proteinase inhibitor in cultured human medullary thyroid carcinoma cells. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[30]  J. Waltho,et al.  The three-dimensional solution structure of human stefin A. , 1995, Journal of molecular biology.

[31]  V. Turk,et al.  Cysteine proteinases and inhibitors in inflammation: their role in periodontal disease. , 1993, Journal of periodontology.

[32]  I. Olafsson,et al.  Hereditary cystatin C amyloid angiopathy , 2000, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[33]  Izabela Berdowska,et al.  Cysteine proteases as disease markers. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[34]  Christopher M. Overall,et al.  Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy , 2006, Nature Reviews Cancer.

[35]  D. P. Dickinson,et al.  The human type 2 cystatin gene family consists of eight to nine members, with at least seven genes clustered at a single locus on human chromosome 20. , 1994, DNA and cell biology.

[36]  J. Kos,et al.  Intracellular delivery of cysteine protease inhibitor cystatin by polymeric nanoparticles. , 2006, Journal of nanoscience and nanotechnology.

[37]  Barrett Aj,et al.  The cystatins: a diverse superfamily of cysteine peptidase inhibitors. , 1986, Biomedica biochimica acta.

[38]  M. Jaskólski,et al.  3D domain‐swapped human cystatin C with amyloidlike intermolecular β‐sheets , 2005, Proteins.

[39]  J. Kos,et al.  Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. , 2003, Experimental cell research.

[40]  Seon-Young Kim,et al.  Upregulation of the cysteine protease inhibitor, cystatin SN, contributes to cell proliferation and cathepsin inhibition in gastric cancer. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[41]  I. Olafsson,et al.  Efficient production of native, biologically active human cystatin C by Escherichia coli , 1988, FEBS letters.

[42]  D. Hanahan,et al.  Inhibition of cysteine cathepsin protease activity enhances chemotherapy regimens by decreasing tumor growth and invasiveness in a mouse model of multistage cancer. , 2007, Cancer research.

[43]  J. Featherstone,et al.  Examination of the potential structure of human salivary cystatins based on computer modelling. , 1997, Archives of oral biology.

[44]  Bonnie F. Sloane,et al.  Unraveling the role of proteases in cancer. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[45]  C. Tseng,et al.  Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system. , 2000, Archives of biochemistry and biophysics.